Skip to main content

Table 6 Characteristics of IBD patients treated with or without biologics in 2014 (n = 4812)

From: Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014

n (%) IBD (total) No Biologics Biologics p a
  n = 4812 n = 4192 n = 620  
Female sex 2695 (56.0) 2461 (56.1) 234 (55.1) ns
Age
 Total (mean, SD) 54.8 (18.0) 55.9 (17.9) 43.6 (15.7) <0.001
 Men (mean, SD) 54.2 (17.5) 55.4 (17.2) 41.8 (15.4)  
 Women (mean, SD) 55.4 (18.5) 56.4 (18.4) 45.1 (15.8)  
Language areab
 German 3778 (78.5) 3473 (79.2) 305 (71.8) <0.001
 French 687 (14.3) 582 (13.3) 105 (24.7)  
 Italian 347 (7.2) 332 (7.6) 15 (3.5)  
Type of residence (urban area) 3799 (78.9) 3446 (78.6) 353 (83.1) 0.03
Health insurance plan
 Managed care 2340 (48.6) 2154 (49.1) 186 (43.8) 0.04
 Higher deductible 522 (10.8) 509 (11.6) 13 (3.1) <0.001
 Accident coverage 2871 (59.7) 2660 (60.6) 211 (49.7) <0.001
 Supplementary hospital insurance 1020 (21.2) 948 (21.6) 72 (16.9) 0.03
Home care nursing dependency 285 (5.9) 263 (6.0) 22 (5.2) <0.001
  1. a p-values, assigning the differences between IBD patients treated with and without biologics, were calculated using fisher’s exact test for dichotomous variables, using Wilcoxon rank sum test for continuous, and using chi-squared test for categorical variables; ns = not significant